Relay Therapeutics Inc. Common Stock vs Truist Financial Corporation Common Stock — how do they compare? Relay Therapeutics Inc. Common Stock trades at $17.39 (market cap $3.94B), while Truist Financial Corporation Common Stock trades at $46.1 (market cap $55.68B). The key difference: Truist Financial Corporation Common Stock is far larger — about 14.1× Relay Therapeutics Inc. Common Stock's market cap, and Truist Financial Corporation Common Stock pays a 4.56% dividend while Relay Therapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Relay Therapeutics Inc. Common Stock for 0 Days and Truist Financial Corporation Common Stock for 0 Days on average.
| RLAY | TFC | |
|---|---|---|
Market Cap | $3.94B | $55.68B |
Volume | 3,432,928 | 7,292,374 |
Sector | Health | Financials |
52-Week High | $20.75 | $55.81 |
52-Week Low | $6.03 | $41.09 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $3.06B | $121.94B |
Dividend Yield | — | 4.56% |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Relay Therapeutics develops precision medicines for oncology and genetic diseases. Its drug discovery platform studies how protein motion affects drug targets to guide small-molecule medicine design.
Read more on RLAY →Truist Financial provides consumer and commercial banking, wealth management, insurance, and investment services in the United States.
Read more on TFC →